Transformation to a squamous cell carcinoma phenotype of an EGFR-mutated NSCLC patient after treatment with an EGFR-tyrosine kinase inhibitor

J.L. Kuiper*, M.I. Ronden, A. Becker, D.A.M. Heideman, P. van Hengel, B. Ylstra, E. Thunnissen, E.F. Smit

*Corresponding author for this work

Research output: Contribution to journalLetterAcademicpeer-review

Original languageEnglish
Pages (from-to)320-321
Number of pages2
JournalJournal of Clinical Pathology
Volume68
Issue number4
DOIs
Publication statusPublished - 1 Jan 2015

Cite this